Search Results

There are 12306 results for: content related to: Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients 1

  1. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma


    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  2. You have free access to this content
    Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy


    Volume 118, Issue 23, 1 December 2012, Pages: 5857–5866, Silvia Stacchiotti, Paolo Verderio, Antonella Messina, Carlo Morosi, Paola Collini, Antonio Llombart-Bosch, Javier Martin, Alessandro Comandone, Jurado Cruz, Andrea Ferraro, Giovanni Grignani, Sara Pizzamiglio, Vittorio Quagliuolo, Piero Picci, Sergio Frustaci, Angelo Paolo Dei Tos, Paolo G. Casali and Alessandro Gronchi

    Version of Record online : 17 MAY 2012, DOI: 10.1002/cncr.27624

  3. mRECIST to Predict Survival in Advanced HCC: Analysis of Two Randomised Phase II Trials Comparing Nintedanib versus Sorafenib

    Liver International

    Accepted manuscript online: 9 JAN 2017, Tim Meyer, Daniel H. Palmer, Ann-Lii Cheng, Julia Hocke, Arsène-Bienvenu Loembé and Chia-Jui Yen

    DOI: 10.1111/liv.13359

  4. You have free access to this content
    Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma


    Volume 62, Issue 4, October 2015, Pages: 1111–1121, Adeel R. Seyal, Fernanda D. Gonzalez-Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem and Vahid Yaghmai

    Version of Record online : 19 JUN 2015, DOI: 10.1002/hep.27915

  5. You have free access to this content
    Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors


    Volume 121, Issue 21, November 1, 2015, Pages: 3826–3835, Alexander M. Menzies, James S. Wilmott, Martin Drummond, Serigne Lo, Megan Lyle, Matthew M. K. Chan, John F. Thompson, Alex Guminski, Matteo S. Carlino, Richard A. Scolyer, Richard F. Kefford and Georgina V. Long

    Version of Record online : 28 JUL 2015, DOI: 10.1002/cncr.29586

  6. You have free access to this content
    A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma


    Volume 121, Issue 10, May 15, 2015, Pages: 1620–1627, Mairéad G. McNamara, Lisa W. Le, Anne M. Horgan, Alex Aspinall, Kelly W. Burak, Neesha Dhani, Eric Chen, Mehrdad Sinaei, Glen Lo, Tae Kyoung Kim, Patrik Rogalla, Oliver F. Bathe and Jennifer J. Knox

    Version of Record online : 6 JAN 2015, DOI: 10.1002/cncr.29227

  7. You have full text access to this OnlineOpen article
    Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives

    Cancer Medicine

    Volume 2, Issue 5, October 2013, Pages: 674–686, Kristina Buder, Anja Gesierich, Götz Gelbrich and Matthias Goebeler

    Version of Record online : 18 SEP 2013, DOI: 10.1002/cam4.133


    Veterinary Radiology & Ultrasound

    Volume 55, Issue 2, March/April 2014, Pages: 115–132, John H. Rossmeisl Jr., Paulo A. Garcia, Gregory B. Daniel, John Daniel Bourland, Waldemar Debinski, Nikolaos Dervisis and Shawna Klahn

    Version of Record online : 13 NOV 2013, DOI: 10.1111/vru.12118

  9. You have free access to this content
    Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)


    Volume 116, Issue 9, 1 May 2010, Pages: 2258–2265, Veridiana Pires de Camargo, Mary L. Keohan, David R. D'Adamo, Cristina R. Antonescu, Murray F. Brennan, Samuel Singer, Linda S. Ahn and Robert G. Maki

    Version of Record online : 24 FEB 2010, DOI: 10.1002/cncr.25089

  10. Can response to locoregional therapy help predict long-term survival after liver transplantation for hepatocellular carcinoma? A systematic review

    Liver Transplantation

    Accepted manuscript online: 22 DEC 2016, Paul D. Morris, Jerome M. Laurence, David Yeo, Michael Crawford, Simone I. Strasser, Geoffrey W. McCaughan and Charbel Sandroussi

    DOI: 10.1002/lt.24689

  11. You have free access to this content
    Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer

    International Journal of Cancer

    Volume 136, Issue 11, 1 June 2015, Pages: 2730–2737, Michael Luke Marinovich, Nehmat Houssami, Petra Macaskill, Gunter von Minckwitz, Jens-Uwe Blohmer and Les Irwig

    Version of Record online : 25 NOV 2014, DOI: 10.1002/ijc.29323

  12. You have free access to this content
    The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition


    Volume 120, Issue 20, October 15, 2014, Pages: 3142–3153, Matthew M. K. Chan, Lauren E. Haydu, Alexander M. Menzies, Mary W. F. Azer, Oliver Klein, Megan Lyle, Arthur Clements, Alexander Guminski, Richard F. Kefford and Georgina V. Long

    Version of Record online : 1 JUL 2014, DOI: 10.1002/cncr.28851

  13. You have free access to this content
    Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators


    Volume 118, Issue 23, 1 December 2012, Pages: 5749–5756, Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale, Gauri Varadhachary, Jeffrey E. Lee, Robert Wolff, Huamin Wang, James Abbruzzese, Peter W. T. Pisters, Jean-Nicolas Vauthey, Chusilp Charnsangavej, Eric Tamm, Christopher H. Crane and Aparna Balachandran

    Version of Record online : 17 MAY 2012, DOI: 10.1002/cncr.27636

  14. You have full text access to this Open Access content
    Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients

    Cancer Science

    Volume 97, Issue 3, March 2006, Pages: 214–218, Hirokazu Watanabe, Hideo Kunitoh, Seiichiro Yamamoto, Shin Kawasaki, Akira Inoue, Katsuyuki Hotta, Kazu Shiomi, Masahiko Kusumoto, Kazuro Sugimura and Nagahiro Saijo

    Version of Record online : 14 FEB 2006, DOI: 10.1111/j.1349-7006.2006.00157.x

  15. You have free access to this content
    Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancer


    Volume 118, Issue 18, 15 September 2012, Pages: 4486–4494, D. Ross Camidge, Mariana Theodoro, DeLee A. Maxson, Margaret Skokan, Tara O'Brien, Xian Lu, Robert C. Doebele, Anna E. Barón and Marileila Varella-Garcia

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.27411

  16. You have free access to this content
    Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 543–555, Stefan S. De Buck, Annamaria Jakab, Markus Boehm, Douglas Bootle, Dejan Juric, Cornelia Quadt and Timothy K. Goggin

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12378

  17. You have free access to this content
    Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis


    Volume 118, Issue 6, 15 March 2012, Pages: 1649–1655, Philippe A. Cassier, Hans Gelderblom, Silvia Stacchiotti, David Thomas, Robert G. Maki, Judith R. Kroep, Winette T. van der Graaf, Antoine Italiano, Beatrice Seddon, Julien Dômont, Emanuelle Bompas, Andrew J. Wagner and Jean-Yves Blay

    Version of Record online : 5 AUG 2011, DOI: 10.1002/cncr.26409

  18. Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)

    Hepatology Research

    Volume 40, Issue 7, July 2010, Pages: 686–692, Masatoshi Kudo, Shouji Kubo, Kenichi Takayasu, Michiie Sakamoto, Masatoshi Tanaka, Iwao Ikai, Junji Furuse, Kenji Nakamura, Masatoshi Makuuchi and for The Liver Cancer Study Group of Japan (Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan)

    Version of Record online : 14 JUL 2010, DOI: 10.1111/j.1872-034X.2010.00674.x

  19. You have free access to this content
    Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques


    Volume 54, Issue 6, December 2011, Pages: 2238–2244, Jordi Bruix, Maria Reig, Jordi Rimola, Alejandro Forner, Marta Burrel, Ramón Vilana and Carmen Ayuso

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24670

  20. You have free access to this content
    Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma


    Volume 118, Issue 12, 15 June 2012, Pages: 3191–3198, Tracy R. Price, Susan M. Perkins, Kumar Sandrasegaran, Mark A. Henderson, Mary A. Maluccio, Jennifer E. Zook, A. Joseph Tector, Rodrigo M. Vianna, Peter A.S. Johnstone and Higinia R. Cardenes

    Version of Record online : 24 OCT 2011, DOI: 10.1002/cncr.26404